Monitoring mycophenolate mofetil is necessary for the effective prophylaxis of acute GVHD after cord blood transplantation.
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Y
Y
Arai
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
T
0000000176784284
T
Kondo
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
T
T
Kitano
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
M
M
Hishizawa
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
K
K
Yamashita
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
N
N
Kadowaki
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
T
T
Yamamoto
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
I
I
Yano
Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.
K
K
Matsubara
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
A
A
Takaori-Kondo
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D064591:Allografts; D036101:Cord Blood Stem Cell Transplantation; D016903:Drug Monitoring; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood; D007938:Leukemia / Q000097:blood / Q000628:therapy; D008223:Lymphoma / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid